Aurinia Pharmaceuticals (GB:0UJF)

Aurinia Pharmaceuticals Financial Statements


Aurinia Pharmaceuticals Financial Overview

Aurinia Pharmaceuticals's market cap is currently ―. The company's EPS TTM is C$-1.054; its P/E ratio is -14.62; Aurinia Pharmaceuticals is scheduled to report earnings on March 9, 2023, and the estimated EPS forecast is C$-0.37. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Mar 22Dec 21Sep 21Jun 21
Income Statement
Total Revenue$ 28.19M$ 21.63M$ 23.40M$ 14.67M$ 6.62M
Gross Profit$ 26.59M$ 21.37M$ 22.92M$ 14.41M$ 6.31M
EBIT$ -35.99M$ -37.88M$ -32.70M$ -50.35M$ -47.13M
EBITDA$ -35.15M$ -37.04M$ -32.02M$ -49.67M$ -46.16M
Net Income Common Stockholders$ -35.52M$ -37.63M$ -33.32M$ -50.26M$ -47.01M
Balance Sheet
Cash, Cash Equivalents and Short-Term Investments$ 391.74M$ 418.75M$ 466.08M$ 286.40M$ 318.74M
Total Assets$ 482.15M$ 506.90M$ 543.37M$ 360.07M$ 386.27M
Total Debt$ 8.38M$ 8.57M$ 8.74M$ 8.91M$ 8.94M
Net Debt$ -383.35M$ -410.18M$ -457.34M$ -277.49M$ -309.80M
Total Liabilities$ 58.38M$ 58.78M$ 64.28M$ 61.89M$ 54.01M
Stockholders Equity$ 423.77M$ 448.12M$ 479.09M$ 298.17M$ 332.26M
Cash Flow
Free Cash Flow$ -27.79M$ -46.83M$ -25.96M$ -40.31M$ -38.20M
Operating Cash Flow$ -27.87M$ -46.75M$ -25.92M$ -40.25M$ -37.98M
Investing Cash Flow$ 45.62M$ -53.02M$ -5.49M$ -32.81M$ 1.67M
Financing Cash Flow$ 1.34M$ 405.00K$ 205.72M$ 9.08M$ 1.28M
Currency in USD

Aurinia Pharmaceuticals Earnings and Revenue History

Aurinia Pharmaceuticals Debt to Assets

Aurinia Pharmaceuticals Cash Flow

Aurinia Pharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis